CDKN2A and cancer: This protein, with CDK4 and CDK6 kinases, form a complex that blocks the phosphorylation of Rb, making p16 a final key factor in stabilizing senescence, which is the main reason why cancer cells frequently have mutations in p16 rather than in p21 [58].